Investor AB account plan
Investment in Nordic companies
At a glance
Investor AB is the Wallenberg-founded Swedish holding company behind ABB, Atlas Copco, Saab and Mölnlycke; adjusted NAV SEK 1,258.0bn at 30 Sept 2026.
Investor AB, founded by the Wallenberg family in 1916 and listed on Nasdaq Stockholm, is a holding company that builds businesses through substantial ownership and board participation. It works in three business areas: Listed Companies (significant minority stakes in Nordic-rooted multinationals), Patricia Industries (wholly owned private companies in healthcare, industrial technology and real estate) and Investments in EQT. Its companies employ more than 500,000 people, and Investor holds more than 200 board seats in them. Adjusted net asset value was SEK 1,087bn at year-end 2025 and SEK 1,258.0bn at 30 September 2026; the Knut and Alice Wallenberg Foundation holds 43.0 percent of the votes. Christian Cederholm is President and CEO and Jacob Wallenberg is Chair.
Business units
Listed Companies
72% of total adjusted assets at 31 Dec 2025 (SEK 798bn); 74 percent at 30 Sept 2026Minority stakes, often as largest shareholder, in 13 global companies including ABB, Atlas Copco, Saab, AstraZeneca, SEB, Nasdaq, Epiroc, Sobi, Wärtsilä and Ericsson. It returned 22% in 2025 and 21 percent over the first nine months of 2026; ABB alone was 20 percent of total assets at 30 September 2026. Led by Daniel Nodhäll.
Patricia Industries
19% of total adjusted assets at 31 Dec 2025 (SEK 208bn)Builds private companies in the Nordics and North America, chiefly Mölnlycke, Laborie, Nova Biomedical, Sarnova, Permobil, Piab Group, BraunAbility, Vectura and 40% of Tre Skandinavien. LTM sales were SEK 72.8bn and EBITDA SEK 19.0bn at Q3 2026, when major subsidiaries grew 7 percent organically and returned 15 percent. Co-led by Thomas Kidane and Yuriy Prilutskiy.
Investments in EQT
9% of total adjusted assets at 31 Dec 2025 (SEK 104bn)Holds 14.4% of EQT AB, as its largest owner, plus commitments to EQT funds, mostly the flagship Equity and Infrastructure funds. Value change was -9 percent over the first nine months of 2026; fund investments have a net IRR of 19% from 2019 to Q3 2026. Led by Petra Hedengran.
Strategic priorities
- Performance, Portfolio and People
- The strategy targets total shareholder return by growing NAV, paying a steadily rising dividend and operating efficiently and sustainably, with an annual return requirement of 8-9%.
- Future-proofing through AI and innovation
- Investor pushes its companies to embed AI across the value chain and to move from experiments to scaling select use cases, alongside R&D through the cycle and succession planning.
- Support existing companies first
- Capital goes first to existing companies (organic growth and add-ons), then to the dividend, then selectively to new platform companies; capital is not earmarked by business area.
- New platforms in North America
- Patricia Industries is looking for new US platforms in industrial technology, software, healthcare and services, and Listed Companies is open to a new large Nordic holding.
- Competing with China
- Management says Chinese rivals lead on cost and innovation, so portfolio companies must be present in China from R&D to production.
- Portfolio emissions
- Target of an 80% reduction in portfolio scope 1 and 2 emissions by 2030 vs 2016; emissions were down 74% at end 2025.
Latest results
For January-September 2026, adjusted NAV rose 17 percent with dividend added back, to SEK 1,258.0bn (SEK 411 per share) at 30 September, and Q3 growth was 4 percent. Total shareholder return was 24 percent over nine months against 11 percent for the SIXRX index. Listed Companies returned 21 percent over nine months, while Patricia Industries returned 15 percent in Q3 as major subsidiaries grew sales 12 percent (7 percent organic) and adjusted EBITA 26 percent, helped by tariff refunds. Investments in EQT fell 9 percent over nine months. Leverage was 1.8 percent, and Moody's upgraded Investor to Aa2.
Investments and deals
- Patricia Industries add-ons
- Subsidiaries made SEK 24bn of add-on acquisitions in 2025, led by Advanced Instruments' USD 2.2bn purchase of Nova Biomedical; Laborie bought the JADA system for up to USD 465m and Sarnova bought Mercury Medical for USD 43m in 2026.
- Mölnlycke separation
- Mölnlycke intends to split into Mölnlycke (Wound Care, Antiseptics) and Mölnlycke Surgical (Operating Room Solutions, Gloves); it is also investing EUR 115m in Wound Care manufacturing in Maine, US.
- Listed holdings top-ups
- SEK 1.7bn invested in Ericsson and SEK 0.6bn in Atlas Copco in 2025, and SEK 1,701m subscribed in the Electrolux rights issue in 2026.
- EQT co-investment and funds
- A first co-investment of SEK 4.5bn alongside EQT X in Fortnox, about SEK 6 billion added to EQT AB shares in 18 months, and a commitment to the European Scaleup Fund.
- Vectura property for Saab
- Vectura signed an 80,000 sqm R&D site in Jönköping for Saab, funded by SEK 500m from Patricia, with completion expected 2029.
Challenges and risks
- Share price and concentration risk
- Share price risk is the largest financial risk and is not hedged; ABB, Atlas Copco, SEB, Saab and AstraZeneca make up around 75% of Listed Companies.
- Geopolitics and tariffs
- Wars, geopolitical instability, elevated tariffs and policy uncertainty are named as the most significant commercial risks.
- Technology shift
- Failure to adapt to digital transformation is a named strategic risk; the CEO warns that AI will quickly turn into a threat if not leveraged.
- Underperforming companies
- Electrolux and Husqvarna are under turnaround plans, Permobil had muted growth, and Investments in EQT fell 9 percent over nine months of 2026.
What leadership says
“We win when our companies win.”
“arguably the biggest technology shift we have seen since electrification”
“Our top priority has always been and must always be to invest and build the companies we have”
“Selling on the margin is not really a tool in our toolbox”
Where a supplier can help
- AI use cases across portfolio companies
- Tied to the future-proofing priority: Investor wants companies to scale select AI initiatives in R&D, production and go-to-market, which favours providers who can prove value in one company and repeat it in others.
- Integration support for add-ons
- Tied to the Patricia Industries add-on investments such as Nova Biomedical, JADA and Mercury Medical: integration, systems and commercial-excellence suppliers fit a model built on acquisitions.
- Separation services for Mölnlycke
- Tied to the Mölnlycke separation: carving out Mölnlycke Surgical creates needs for standalone systems, processes and organisation.
- Decarbonisation across the portfolio
- Tied to the 2030 portfolio emissions target and the requirement for scope 3 and circularity targets: energy, measurement and supply-chain decarbonisation offers apply across many holdings.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Investor AB?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Annual Report 2025
- Investor AB, founded by the Wallenberg family in 1916, is a Swedish holding company that builds companies through "substantial ownership and board participation", organised in three business areas: Listed Companies, Patricia Industries and Investments in EQT; its companies employ more than 500,000 people.
- Adjusted net asset value reached SEK 1,087bn at year-end 2025 (970), growth of 14 percent with dividend added back (20); total shareholder return was 15 percent vs 13 percent for the SIXRX index, the 15th consecutive year of outperformance per the Chair.
- Portfolio mix at 31 Dec 2025 (share of total adjusted assets): Listed Companies SEK 798bn (72%), Patricia Industries SEK 208bn (19%), Investments in EQT SEK 104bn (9%); largest holdings ABB (16%), Atlas Copco (13%), Saab, AstraZeneca and SEB (8% each).
- Listed Companies returned 22 percent; Investor bought SEK 1.7bn of Ericsson and SEK 0.6bn of Atlas Copco and sold SEK 1.7bn of SEB to keep its ownership share.
- Patricia Industries returned -9 percent (currency and lower multiples) although its major subsidiaries grew organic sales 4 percent in constant currency; subsidiaries made SEK 24bn of add-on acquisitions, led by Advanced Instruments' USD 2.2bn purchase of Nova Biomedical.
- Strategy rests on three pillars, Performance, Portfolio and People; annual return requirement 8-9 percent; capital priorities are to support existing companies, pay a steadily rising dividend and add new platform companies selectively. Proposed dividend SEK 5.60 per share (5.20).
- Balance sheet: net debt SEK 23,387m, leverage 2.1 percent (target range 0-10 percent), gross cash SEK 27,119m.
- Priorities for 2026: keep companies performing in the current market and accelerate future-proofing (sustainability, innovation, new technology including AI, succession and talent). Main risks: share price risk, geopolitics and tariffs, technology shift, cyber security, key people.
- Interim Management Statement January-September 2026
- Adjusted NAV was SEK 1,258.0bn (SEK 411 per share) at 30 September 2026, up 4 percent in Q3 and 17 percent over nine months with dividend added back; nine-month TSR 24 percent vs 11 percent for SIXRX.
- Listed Companies returned 1 percent in Q3 and 21 percent over nine months; dividends received SEK 14,774m year to date, including SEK 2,522m of extra dividends; ABB is now 20 percent of total assets (SEK 252,810m).
- Patricia Industries returned 15 percent in Q3 on estimated market values; major subsidiaries grew sales 12 percent (7 percent organic in constant currency), EBITA +23 percent and adjusted EBITA +26 percent; LTM sales SEK 72.8bn and EBITDA SEK 19.0bn.
- Mölnlycke grew 5 percent organically (Wound Care 6 percent) and announced it intends to separate Operating Room Solutions and Gloves into a new standalone company.
- Nova Biomedical +14 percent organic, Laborie +13 percent, Sarnova +8 percent (bought Mercury Medical for USD 43m); Vectura signed an 80,000 sqm R&D site in Jönköping for Saab, funded by SEK 500m from Patricia.
- Investments in EQT value change 7 percent in Q3 (-9 percent over nine months); net cash flow to Investor SEK -663m in Q3; Investor committed capital to the European Scaleup Fund.
- Leverage 1.8 percent, gross cash SEK 29,460m, debt maturity 8.4 years; rolling 12-month management cost SEK 802m (0.06 percent of NAV).
- CEO: companies balance current performance with investment in innovation, particularly AI; Europe must turn ambition on the single market into action.
- Investor Q3 2026 results call (transcript)
- Q3 2026 results call (16 Oct 2026) with CEO Christian Cederholm and CFO Jenny Ashman Haquinius: adjusted NAV +4% to SEK 1,258bn; Patricia Industries +15%, Investments in EQT +7%, Listed Companies 1%.
- Patricia's major subsidiaries grew 7% organically with adjusted EBITA +26%, helped by M&A, currency and a few percentage points of tariff refunds (roughly a percentage point of margin where highlighted); management believes most tariff refunds have now been seen.
- Mölnlycke will split into Mölnlycke (Wound Care, Antiseptics) and Mölnlycke Surgical (ORS, Gloves) for focus and accountability; Cederholm says the aim is not to sell either company or re-rate on peer multiples, and accepts some duplicated cost.
- Wound Care grew 6% with strength in Canada and China, but tough US competition in prevention and French healthcare budget pressure; mature Wound Care markets grow low to mid-single digits.
- Nova Biomedical +14% organic (easy comparison after a cyber incident; historical market growth around 8%); Laborie +13% led by Optilume urethral strictures; Optilume BPH still early, building clinical evidence after a first US reimbursement code.
- Capital allocation: first support existing companies, second a steadily rising dividend, third new platform companies; no fixed split by business area.
- No trimming of ABB (about 20% of NAV): "Selling on the margin is not really a tool in our toolbox"; SEB share sales are driven by regulatory considerations, not policy.
- Moody's upgraded Investor from Aa3 to Aa2; leverage 1.8%, about SEK 29bn of cash.
- Investor Capital Markets Update 2026 (transcript)
- Capital Markets Update, 4 Nov 2026: CEO Christian Cederholm restated the strategy (grow NAV, steadily rising dividend, efficient and sustainable operations) around three Ps: Performance, Portfolio and People, across 24 non-competing companies.
- Future-proofing themes: innovation, AI ("arguably the biggest technology shift we have seen since electrification"), sustainability, China competition and people; companies are moving from AI experiments to scaling select use cases.
- Capital allocation: existing companies first, then a rising dividend, then new platform companies; Investor expects capacity to invest more in the next 5-10 years than in the last, and does not earmark capital by business area.
- CFO: five-year NAV growth 16% a year, 10-year dividend growth 8% a year, management cost 0.06% of NAV, leverage at the low end of 0-10%, Moody's upgrade to Aa2, no major maturities until 2030; 2015-2025 cash flow sources SEK 216bn.
- Listed Companies (13 holdings, top five about 75%): SEK 25bn invested over 10 years at about 20% IRR; open to a new large Nordic holding; Electrolux and Husqvarna under turnaround plans.
- EQT: SEK 95bn; fund net IRR 19% since 2019; right to invest 3% of EQT funds carry-free; SEK 6bn added to EQT AB in 18 months; Fortnox co-investment SEK 4.5bn.
- Patricia Industries: about 120 add-ons since 2015, 70% of capital to add-ons, 6 to 10 companies (soon 11), 14 to 32 business units, Nordic/North American split 50/50; return 13% over time; looking for new US platforms in industrial tech, software, healthcare and services.
- China: Chinese rivals lead "not only on cost efficiency, but also on innovations"; companies must be on the ground in China from R&D to production.
Questions about Investor AB
What does Investor AB do?
Investor AB is a Swedish holding company that owns significant stakes in listed companies such as ABB, Atlas Copco and Saab, owns private companies through Patricia Industries, and invests in EQT.
How large is Investor AB?
Adjusted net asset value was SEK 1,258.0bn at 30 September 2026, and its companies employ more than 500,000 people.
Who leads Investor AB?
Christian Cederholm is President and CEO, Jenny Ashman Haquinius is CFO and Jacob Wallenberg is Chair.
What is Investor AB's strategy?
It aims for attractive total shareholder return through three pillars, Performance, Portfolio and People, investing first in existing companies, then in a steadily rising dividend, then in new platform companies.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)